On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence?
- PMID: 29030331
- DOI: 10.1158/1078-0432.CCR-17-2332
On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence? (VSports手机版)
Abstract
The larger fraction of patients treated with immune checkpoint inhibitors remain nonresponding eventually. Combination of checkpoint inhibitor and costimulatory antibodies is thought additive, but for such effect, they may require to be given in the right sequence. Clin Cancer Res; 23(20); 5999-6001 VSports手机版. ©2017 AACRSee related article by Messenheimer et al. , p. 6165. .
©2017 American Association for Cancer Research V体育安卓版. .
Publication types
- Actions (VSports手机版)
MeSH terms (V体育平台登录)
- V体育官网 - Actions
- "VSports手机版" Actions
- V体育平台登录 - Actions
- "VSports在线直播" Actions
- Actions (V体育平台登录)
- "V体育ios版" Actions
- Actions (V体育平台登录)
- "VSports在线直播" Actions
- VSports手机版 - Actions
- V体育平台登录 - Actions
Substances (V体育ios版)
- V体育官网 - Actions
LinkOut - more resources
Full Text Sources (VSports手机版)
Other Literature Sources